Based on Roche's Molecular Work Area concept, the cobas® 5800 System enables laboratories to transform their approach to molecular testing through automation, consolidation, integration and standardisation.
With uniform laboratory processes come measurable improvements in testing quality and efficiency.
Often, technicians require training on a number of workflows to ensure they can run all the tests a laboratory offers. Having all tests run the same way, makes accuracy, efficiency and consistent turnaround times the norm. Regardless of lab location or size, a universal approach enables optimized resource management, minimizing the testing impact of staff shortages or absences. It is for this reason the Molecular Work Area standardizes every part of the testing workflow—from how samples are handled by staff, to how tests are run and how results are delivered.
The Molecular Work Area eliminates extensive, test-specific training with a common user interface, a shared reagent concept, and a range of standalone or connected solution configurations.
Elevated quality
Reliable, reproducible and comparable measurements across healthcare systems to improve diagnoses and clinical decision-making.
Optimized workflow
Streamlined processes improve efficiency, reduce times to result, and allow lab staff to focus on higher value tasks.
Better customer satisfaction
Provide ordering physicians with reliable information faster while potentially reducing cost and improving revenue.
Enhanced efficiency
Common workstreams result in fewer errors, duplications, and delays to drive potential cost savings.
Improved output
Reduced human error and fewer manual steps expedites the delivery of quality results.
Streamlined staff training
Fewer variations in testing processes and workflows can make onboarding new staff simpler.
Common approaches to molecular instrumentation, testing, and patient management can be important to ensure consistent care. Immunocompromised transplant recipients, for instance, are at risk of major complications when infected with Epstein-Barr or BK viruses. Standardized testing could allow patient results to be compared across laboratories and institutions to improve clinical decision-making and help healthcare professionals assess if transplant patients are at risk of developing disease, which can contribute to organ rejection.
As the broader healthcare environment continues to change, laboratories that embrace standardization can establish themselves as the foundation on which future policies, procedures and best practices are built.
Based on Roche's Molecular Work Area concept, the cobas® 5800 System enables laboratories to transform their approach to molecular testing through automation, consolidation, integration and standardisation.